Abstract
To derive an efficient system for gene silencing in human hematopoietic stem cells we modified a lentiviral vector for small interfering RNA (siRNA) delivery. For this purpose, an H1-promotor driven siRNA expression cassette was introduced into a lentiviral vector and the p53 mRNA was chosen as a target for siRNA mediated gene silencing. Using the recombinant lentivirus we infected human cord blood derived CD34 + cells and obtained a transfection efficiency of up to 50%, as determined by expression of enhanced green fluorescent protein (EGFP). In EGFP positive LTC-IC and CFU-C derived cells we observed a reduction of p53 mRNA of up to 95%. Importantly, this reduction remained stable during several weeks of cell culture. Furthermore, p53 gene silencing resulted in decreased p21 mRNA levels and reduced the sensitivity of CD34 + cells towards the cytotoxic drug etoposide. Thus, lentiviral delivery of siRNA can allow for efficient and stable gene silencing in human HSC and will be very valuable for further gene function studies.
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Introduction
Gene silencing by siRNA has become a powerful and rapidly evolving experimental method for studying gene function in mammalian cells. 1, 2 The use of siRNA in hematopoietic stem cells (HSC) is limited by the difficulty of delivering RNA or DNA into HSC by conventional transfection methods. Lentiviral vectors have been shown to efficiently transduce human HSC. [3] [4] [5] [6] Lentiviruses are able to infect non-dividing primary cells and transcription from integrated viruses remains stable over time. 7, 8 Lentiviral vectors have been used to deliver siRNA in some primary mouse and human tissues.
9,10
Here we show that efficient gene silencing can be achieved in human HSC by a lentiviral system designed for delivering siRNA.
Materials and Methods
Constructs
To allow efficient transfer of the H1 promoter/siRNA cassette, we introduced a second ClaI site into pSUPER 11 by ligating the adaptor 5'-AATTATCGATGTTGTAAAAC-3'
and 5'-AATTGTTTTACAACATCGAT-3' into the unique EcoRI site. The template for human p53 siRNA was generated by ligating the annealed primers 5'-GATCCCCGACTCCAGTGGTAATCTACTTCAAGAGAGTAGATTACCACTGGAG Growth factors were used at concentrations of 50 ng/ml for MGDF and 100 ng/ml for Flt- The conditions for RT-PCR of the ribosomal protein L19 (RPL19) were described elsewhere. 15 All reactions were run in duplicate using the ABI 7000 Sequence Detection System (Applied Biosystems, Foster City, CA).
Quantification of apoptosis by flow cytometry
Apoptosis was assessed using the Annexin V-PE Apoptosis Detection Kit I (BD Biosciences, San Diego, CA).
Results and discussion
Since lentiviruses can efficiently transduce human hematopoietic cells, 13 we tested whether the lentiviral vector pWPXL can be used for siRNA mediated gene silencing in human HSC. To allow for a convenient transfer of a cassette comprising the H1 promoter and the siRNA template into pWPXL, we modified the polylinker of the vector pSUPER by introducing a second ClaI site (Fig. 1A) . As a target gene we chose the p53 mRNA, because the conditions for efficient p53 gene silencing have already been established in other cell types. 11 The resulting lentiviral vector pWPXL-p53si was packaged and first tested on 293T cells, a human embryonal kidney derived cell line. p53 protein expression was clearly reduced in cells infected with pWPXL-p53si, as compared to parental 293T cells (Fig. 1B) . Densitometric analysis at 72 hours post infection revealed that p53
protein was reduced by pWPXL-p53si to 17% of the control. Since 293T cells express only.
For EGFP and CD34, we found that p53 mRNA levels were reduced to 3% ( Fig. 2A) , whereas p53 mRNA levels in EGFP-negative cell fraction remained unchanged (not shown). After 5 weeks in liquid culture, over 90% of cells remained EGFP positive and 2-4% were CD34+/EGFP+ (not shown). In sorted CD34+/EGFP+ cells p53 expression was 11% of the controls ( Fig. 2A ). These results demonstrate persistent gene silencing over time.
To determine whether CFU-C progenitors can be targeted, we plated sorted CD34+/EGFP+ cells in methyl cellulose. By real time PCR, we observed an 8 to 10-fold decrease in p53 mRNA in single colonies derived from p53si transduced progenitors (Fig. 2B) in the controls (Fig. 2D) . To further verify that the observed effects result from p53 gene silencing, we analyzed the expression levels of p21 mRNA, a p53 transcriptional target, in the EGFP-positive fraction of the virus infected cells by real-time PCR. We found that in p53 silenced cells the levels of p21 mRNA were reduced to 16% of the controls (Fig.   2E ). Thus, p53 gene silencing by siRNA in human CD34 + cells resulted in the expected reduction of p53 function.
To demonstrate that not only CFU-C, but also earlier hematopoietic progenitors can be transduced by our vectors, we analyzed p53 expression in sorted CD34+/EGFP+ cells grown for 5 weeks on feeder cells under LTC-IC conditions and in single methyl cellulose colonies derived from LTC-ICs. After 5 weeks of culture, over 90% of cells remained EGFP positive and 0.3% were CD34+/EGFP+ (not shown). We sorted these CD34+/EGFP+ cells and found p53 mRNA expression to be reduced to 9% in pWPXLp53si transduced cells (Fig. 2F) . Furthermore, single methylcellulose colonies derived from LTC-ICs displayed an up to 16-fold reduction in p53 mRNA (Fig. 2G) . These results show that early hematopoietic progenitors of the LTC-IC type were transduced and that siRNA expression was persistent in LTC-IC-derived cells.
In summary, we demonstrate that lentiviral delivery of siRNA can be used for efficient and stable gene silencing in human hematopoietic progenitors. This system will be very valuable to study the function of key regulatory genes in human hematopoiesis. 
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